Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer's and Parkinson's Diseases Seite 1

15.11.2023 - NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) - Cognition Therapeutics, Inc. (NASDAQ: CGTX) is presenting in vivo preclinical results at the Society for Neuroscience’s annual meeting illuminating the role of sigma-2 (σ-2) receptor modulators, including ... Seite 1

Related Keywords

Mary Hamby , Michaelj Fox Foundation , , Small Molecule Therapeutics , Cognition Therapeutics Chart , Ognition Therapeutics Kurs , Ognition Therapeutics Aktie ,